Carson Wealth (CWM LLC)
ANIK icon

Carson Wealth (CWM LLC)’s Anika Therapeutics ANIK Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$201K Buy
13,865
+5,328
+62% +$61.8K ﹤0.01% 2744
2025
Q4 		$82K Buy
8,537
+1,080
+14% +$10.3K ﹤0.01% 3209
2025
Q3 		$70K Buy
7,457
+6,267
+527% +$59.8K ﹤0.01% 3243
2025
Q2 		$13K Buy
1,190
+596
+100% +$7.52K ﹤0.01% 4143
2025
Q1 		$9K Buy
594
+328
+123% +$5.46K ﹤0.01% 4133
2024
Q4 		$4K Sell
266
-99
-27% -$1.95K ﹤0.01% 4269
2024
Q3 		$9K Sell
365
-46
-11% -$1.19K ﹤0.01% 3810
2024
Q2 		$10K Buy
411
+131
+47% +$3.4K ﹤0.01% 3518
2024
Q1 		$7K Hold
280
– – ﹤0.01% 3487
2023
Q4 		$6K Buy
280
+135
+93% +$2.79K ﹤0.01% 3393
2023
Q3 		$3K Sell
145
-42
-22% -$871 ﹤0.01% 3628
2023
Q2 		$5K Buy
187
+5
+3% +$134 ﹤0.01% 3412
2023
Q1 		$5K Buy
182
+49
+37% +$1.46K ﹤0.01% 3258
2022
Q4 		$4K Buy
133
+4
+3% +$114 ﹤0.01% 3258
2022
Q3 		$3K Buy
+129
New +$2.97K ﹤0.01% 3263

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ANIK Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Anika Therapeutics (ANIK) stake by 62% in Q1 2026, buying an estimated $61.8K and bringing the position to 13,865 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #2744.

Carson Wealth (CWM LLC) first reported a position in ANIK in Q3 2022 and has held it in 15 quarters since. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Carson Wealth (CWM LLC) held 13,865 shares of Anika Therapeutics worth $201K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 5,328 Anika Therapeutics shares in Q1 2026, an estimated $61.8K.
  • Anika Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2744 holding.
  • Carson Wealth (CWM LLC) first reported a position in Anika Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.